XOMA Corp Business Finance Contracts & Agreements

123 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Royalty Purchase Agreement between LadRx Corporation and XOMA (US) LLC
Purchase Agreements
XOMA Corp
Biotechnology
2025
Amendment No. 1 to Royalty Purchase Agreement by and among Viracta Therapeutics, Inc., Viracta Royalty Fund, LLC, and XOMA (US) LLC
Purchase Agreements
XOMA Corp
Biotechnology
2025
Description of Capital Stock of XOMA Royalty Corporation
Stock Agreements
XOMA Corp
Biotechnology
2025
Landlord Consent to Assignment and Assumption of Lease by Presidio Trust, Kinnate Biopharma Inc., and Eventbrite, Inc.
Assignment Agreements
XOMA Corp
Biotechnology
CA
2024
Amendment No. 1 to Royalty Purchase Agreement by and among Viracta Therapeutics, Inc., Viracta Royalty Fund, LLC, and XOMA (US) LLC
Purchase Agreements
XOMA Corp
Biotechnology
2024
Payment Interest Purchase Agreement between Talphera, Inc. and XOMA (US) LLC dated January 12, 2024
Purchase Agreements
XOMA Corp
Biotechnology
DE
2024
Sale, Contribution and Servicing Agreement between XOMA (US) LLC, XOMA Corporation, and XRL 1 LLC dated December 15, 2023
Contribution Agreements
XOMA Corp
Biotechnology
DE
2024
Loan Agreement among XRL 1 LLC, Blue Owl Capital Corporation, and Lenders (December 15, 2023)
Loan Agreements
XOMA Corp
Biotechnology
DE
2024
Description of Capital Stock of XOMA Corporation
Equity Distribution Agreements
XOMA Corp
Biotechnology
2024
Warrant to Purchase Common Stock Agreement between XOMA Corporation and Blue Owl Capital Corporation (December 15, 2023)
Warrant Agreements
XOMA Corp
Biotechnology
NY
2023
Warrant to Purchase Common Stock Agreement between XOMA Corporation and Blue Owl Capital Corporation (December 2023)
Warrant Agreements
XOMA Corp
Biotechnology
NY
2023
Warrant to Purchase Common Stock between XOMA Corporation and Blue Owl Capital Corporation (December 15, 2023)
Warrant Agreements
XOMA Corp
Biotechnology
NY
2023
Royalty Purchase Agreement between LadRx Corporation and XOMA (US) LLC dated June 21, 2023
Purchase Agreements
XOMA Corp
Biotechnology
DE
2023
Assignment and Assumption Agreement between LadRx Corporation and XOMA (US) LLC (June 21, 2023)
Assignment Agreements
XOMA Corp
Biotechnology
NY
2023
Payment Interest Purchase Agreement between Aptevo Therapeutics Inc. and XOMA (US) LLC dated March 29, 2023
Purchase Agreements
XOMA Corp
Biotechnology
DE
2023
Amendment to Officer Employment Agreement between XOMA Corporation and Thomas Burns (November 1, 2022)
Modification Agreements
XOMA Corp
Biotechnology
2023
Intellectual Property Acquisition Agreement between Obseva SA and XOMA (US) LLC dated November 21, 2022
Purchase Agreements
XOMA Corp
Biotechnology
NY
2023
Description of XOMA Corporation Capital Stock
Stock Agreements
XOMA Corp
Biotechnology
2023
Amendment and Restatement to Asset Purchase and License Agreements between XOMA Corporation and Nanotherapeutics, Inc.
Modification Agreements
XOMA Corp
Biotechnology
2022
Commercial Payment Purchase Agreement between Affitech Research AS and XOMA (US) LLC (October 6, 2021)
Purchase Agreements
XOMA Corp
Biotechnology
CA
2022
Description of XOMA Corporation Capital Stock
Equity Distribution Agreements
XOMA Corp
Biotechnology
2022
Royalty Purchase Agreement among Kuros Biosciences AG, Kuros US LLC, Kuros Royalty Fund (US) LLC, and XOMA (US) LLC dated July 14, 2021
Purchase Agreements
XOMA Corp
Biotechnology
CA
2021
At Market Issuance Sales Agreement between XOMA Corporation and B. Riley Securities, Inc. (August 5, 2021)
Equity Distribution Agreements
XOMA Corp
Biotechnology
NY
2021
Royalty Purchase Agreement between Viracta Therapeutics, Inc. and XOMA (US) LLC, dated March 22, 2021
Purchase Agreements
XOMA Corp
Biotechnology
CA
2021
Deposit Agreement between XOMA Corporation and American Stock Transfer & Trust Company, LLC for 8.375% Series B Cumulative Perpetual Preferred Stock Depositary Shares
Deposit Agreements
XOMA Corp
Biotechnology
NY
2021
Underwriting Agreement for 1,400,000 Depositary Shares of 8.375% Series B Preferred Stock – XOMA Corporation and B. Riley Securities, Inc.
Underwriting Agreements
XOMA Corp
Biotechnology
CA
2021
Amendment No. 1 to Common Stock Sales Agreement between XOMA Corporation and H.C. Wainwright & Co., LLC
Equity Distribution Agreements
XOMA Corp
Biotechnology
NY
2021
Description of XOMA Corporation Capital Stock (Common and Preferred)
Stock Agreements
XOMA Corp
Biotechnology
2021
Underwriting Agreement for 8.625% Series A Cumulative Perpetual Preferred Stock between XOMA Corporation and B. Riley Securities, Inc.
Underwriting Agreements
XOMA Corp
Biotechnology
CA
2020
Amendment to CD40 Research, Development and Commercialization Agreement between Novartis Vaccines and Diagnostics, Inc. and XOMA (US) LLC
Modification Agreements
XOMA Corp
Biotechnology
2020
Description of XOMA Corporation Capital Stock (Common and Preferred Stock)
Stock Agreements
XOMA Corp
Biotechnology
2020
Investment Agreement between XOMA Corporation and Investors for Rights Offering Backstop Commitment
Investment Agreements
XOMA Corp
Biotechnology
DE
2019
Royalty Purchase Agreement between Palo Biofarma, S.L. and XOMA (US) LLC dated September 26, 2019
Purchase Agreements
XOMA Corp
Biotechnology
CA
2019
Royalty Purchase Agreement between Aronora, Inc. and XOMA (US) LLC dated April 7, 2019
Purchase Agreements
XOMA Corp
Biotechnology
CA
2019
First Amendment to Loan and Security Agreement between Silicon Valley Bank and XOMA Corporation (and Affiliates)
Modification Agreements
XOMA Corp
Biotechnology
2019
Warrant to Purchase Common Stock Agreement between XOMA Corporation and Silicon Valley Bank (March 4, 2019)
Warrant Agreements
XOMA Corp
Biotechnology
CA
2019
Amendment No. 2 to Common Stock Purchase Agreement between XOMA (US) LLC and Rezolute, Inc.
Stock Agreements
XOMA Corp
Biotechnology
CA
2019
XOMA Corporation and H.C. Wainwright & Co. Common Stock Sales Agreement (December 18, 2018)
Equity Distribution Agreements
XOMA Corp
Biotechnology
NY
2018
Investment Agreement between XOMA Corporation and Investors for Rights Offering Backstop Commitment
Investment Agreements
XOMA Corp
Biotechnology
DE
2018
Royalty Purchase Agreement among Agenus Royalty Fund, LLC, Agenus Inc., and XOMA (US) LLC dated September 20, 2018
Purchase Agreements
XOMA Corp
Biotechnology
DE
2018